Rhome ResearchCJC-1295
Rhome Research's purity-focus record is clean but narrow, led by Retatrutide's identity pass, 99.9% purity, and modest underfill. BPC-157 also clears identity and purity, yet single-batch BP001 evidence, one large overfill, same-day Retatrutide repeats, vendor-sent sampling, and no price/review corroboration leave consistency and trajectory uncertain.
We investigated who actually operates Rhome Research — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Rhome Research rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 13 Jul 2026 | Pass | 6wt3rxx Tested | lab name | View COA | |||
| 13 Jul 2026 | Pass | 5xq87ea Tested | lab name | View COA | |||
About Rhome Research test results from Finnrick
Rhome Research is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 8 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Rhome Research peptides in this dataset are CJC-1295 (2 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 8 recent tests.